Sign In
NewsRadar

Index Ventures

A European technology venture capital fund.

• Show past press releases
• Edit this company

Contact Information
Address:
 
 
Phone:
Fax:
Web:
Contact:
 
 
2, rue de Jargonnant
Geneva 1207
Switzerland
+41 22 737 0000
+41 22 737 0099
http://www.indexventures.com
Pascal Jouin
+41 22 737 0047

Company Facts
Type:
Capital managed:
Companies invested in:  
Investment managers:
Total staff size:
Number of offices:
Min. investment size:
Max. investment size:
Independent Investor (VC)
500 Mln Euro
36
12
24
1
2 Mln Euro
20 Mln Euro
Funding stages:Startups, Early Stages, Expansion
Geo. scope europe:North Europe, West Europe, South Europe
Investment distrib.:Europe 75%, USA 25%
Industry preferences:Internet, Communications, Computer Related, Software, Other

Partners

  • Bernard Dallé
  • David Rimer
  • Francesco De Rubertis
  • Giuseppe Zocco
  • Neil Rimer

    Portfolio

  • Cellzome (acquired by GlaxoSmithKline)
  • 7TM Pharma A/S
  • Virata
  • SCM Microsystems
  • Optimer
  • Neo Vista Software
  • GeneBio
  • Evolve Software
  • ControlMed
  • CommQuest Technologies
  • Calico Commerce
  • ArrayComm
  • Aptix
  • Webfair AG
  • Vitaminic
  • The Fantastic Corporation
  • Structural GenomiX
  • StepStone
  • smarterwork.com
  • Respond.com
  • Ofoto
  • Numerical Technologies, Inc.
  • Mediasurface Limited
  • Listen.com
  • LaserComm
  • Ingenium Pharmaceuticals
  • Genmab
  • Flutter
  • Evolve Software
  • DirectMedica
  • digiquant
  • ciao.com AG (Acquired by Greenfield Online Inc)

    Funds
    NameStatusClosingSize
    Index Ventures IVClosedFeb 2007350 Mln Euro
    Index Ventures IIIClosedFeb 2005300 Mln Euro
    Index Ventures II LPClosedJun 2001300 Mln USD
    Index Ventures I LPClosedNov 1998180 Mln USD
    Index Ventures 0 LPClosedApr 199615 Mln USD

    Remarks
    In the field of IT, Index Ventures currently invests in the following markets: enterprise software, data communications,telecommunications, computing and storage. Within health care, Index focuses on genomics, proteomics, drug discovery platforms, drug delivery mechanisms, monoclonal antibodies as well as cost-containment and disease management.


  • Data


    26,442
    Tech investments
    From our Online Data Service
    17,073
    VC-backed companies
    From our Radar


    Recent Deals


    DATEAMOUNTSECTOR
    Dec 6€9.3MSoftware development
    Dec 6€1.5MConsumer applications
    Dec 6€3.7MInternet commerce
    Dec 5€8.0MNanotechnology
    Dec 5€11.0MBiotechnology
    Dec 5€11.0MRobotics
    Dec 5N/ARobotics

    For information on Europe's most extensive database on technology funding click here!

    Events



    Press Releases


    May 28
    Identiq
    identiq raises $5m seed, launches privacy-first identity validation...

    Apr 29
    Nethone
    nethone raised over $1 million from innovation nest

    Oct 1
    The Link App
    the link app launches version 2.0

    Mar 29
    Addex Therapeutics
    addex sucessfully raises chf40 million in capital increase

    Jan 2
    Urban Jungle
    urban jungle raises 1m in seed funding to build tech-enabled home ...





    About usContact usLegal Information
    Copyright 1999-2019
    Emerging Technology Research Europe Inc. All rights reserved.